Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Aspalatone is an anti-platelet aggregator (IC50 = 180 μM, in vitro) that prolongs bleeding time significantly in a rodent model of thromboembolism. Additionally at a minimal effective dose of 24 mg/kg, aspalatone generates antioxidant and neuroprotective effects against kainic acid-induced epilepsy in rat hippocampus.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 35 days | $ 88.00 | |
10 mg | 35 days | $ 165.00 | |
50 mg | 35 days | $ 685.00 | |
100 mg | 35 days | $ 1,190.00 |
Description | Aspalatone is an anti-platelet aggregator (IC50 = 180 μM, in vitro) that prolongs bleeding time significantly in a rodent model of thromboembolism. Additionally at a minimal effective dose of 24 mg/kg, aspalatone generates antioxidant and neuroprotective effects against kainic acid-induced epilepsy in rat hippocampus. |
Molecular Weight | 288.25 |
Formula | C15H12O6 |
CAS No. | 147249-33-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 1 mg/mL
DMSO: 10 mg/mL
DMF: 10 mg/mL
DMSO:PBS (pH 7.2) (1:10): 0.1 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Aspalatone 147249-33-0 inhibitor inhibit